|
| 37671601 | Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trials. | Eur J Heart Fail | 2024 |
| 38069915 | Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study. | Clin Chem | 2024 |
| 37553153 | Hospital admissions in the last year of life of patients with heart failure. | Eur Heart J Qual Care Clin Outcomes | 2024 |
| 37990754 | Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS-986231). | Eur J Heart Fail | 2024 |
| 37783444 | Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease. | Kidney Int | 2024 |
| 37939716 | Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial. | ESC Heart Fail | 2024 |
| 37984672 | Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis. | Am Heart J | 2024 |
| 37608126 | Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus. | Clin Res Cardiol | 2024 |
| 37875635 | Defining iron deficiency in patients with heart failure. | Nat Rev Cardiol | 2024 |
| 37926238 | The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction. | J Card Fail | 2024 |
| 36004819 | Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. | Cardiovasc Res | 2023 |
| 37712339 | Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. | Eur J Heart Fail | 2023 |
| 37522254 | Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials. | J Cardiovasc Electrophysiol | 2023 |
| 37659583 | Transportability of two heart failure trials to a disease registry using individual patient data. | J Clin Epidemiol | 2023 |
| 37622666 | 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. | Eur Heart J | 2023 |
| 37850512 | Should we resurrect acetazolamide as a diuretic for congestion due to heart failure? | Cardiovasc Res | 2023 |
| 37586715 | Letter regarding the article "Hypocapnia is an independent predictor of in-hospital mortality in acute heart failure". | ESC Heart Fail | 2023 |
| 37694719 | Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial. | Acta Cardiol | 2023 |
| 37649316 | Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. | ESC Heart Fail | 2023 |
| 37940229 | Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. | J Am Coll Cardiol | 2023 |
| 37777041 | Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure). | Am Heart J | 2023 |
| 37728026 | Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy. | Eur J Heart Fail | 2023 |
| 37678961 | Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. | JACC Heart Fail | 2023 |
| 37973338 | Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. | Lancet Glob Health | 2023 |
| 37567750 | Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF. | BMJ Open | 2023 |
| 35723241 | Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure? | Eur Heart J Qual Care Clin Outcomes | 2023 |
| 37461448 | Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis. | medRxiv | 2023 |
| 37354145 | Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF. | JACC Heart Fail | 2023 |
| 37192292 | Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. | Circ Heart Fail | 2023 |
| 37211964 | Coronary revascularization for heart failure with coronary artery disease: A systematic review and meta-analysis of randomized trials. | Eur J Heart Fail | 2023 |
| 37208936 | Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. | Eur J Heart Fail | 2023 |
| 36974770 | Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. | Eur J Heart Fail | 2023 |
| 37400990 | Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. | ESC Heart Fail | 2023 |
| 37130747 | Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. | Heart | 2023 |
| 36997667 | Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure. | Clin Res Cardiol | 2023 |
| 37427007 | Defining Heart Failure Based on Imaging the Heart and Beyond. | Card Fail Rev | 2023 |
| 37062878 | A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trial. | Eur J Heart Fail | 2023 |
| 36883593 | Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. | Cardiovasc Res | 2023 |
| 36786511 | Variation in optimal hemodynamic atrio-ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics. | J Cardiovasc Electrophysiol | 2023 |
| 36402423 | Ketone Bodies in Acute Heart Failure: Fuel for Thought. | J Card Fail | 2023 |
| 36879446 | Redefining both iron deficiency and anaemia in cardiovascular disease. | Eur Heart J | 2023 |
| 36811158 | Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis. | ESC Heart Fail | 2023 |
| 36617216 | Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study). | Eur J Cardiovasc Nurs | 2023 |
| 36472647 | Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. | Clin Res Cardiol | 2023 |
| 36738846 | Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials. | Int J Cardiol | 2023 |
| 36634548 | Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). | Am J Cardiol | 2023 |
| 36894788 | Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity. | Clin Res Cardiol | 2023 |
| 36597719 | Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial. | Eur J Heart Fail | 2023 |
| 36563739 | Combining Iron Supplements With SGLT2 Inhibitor-Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events? | J Card Fail | 2023 |
| 36823953 | Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. | Eur J Heart Fail | 2023 |